Investor Presentation - Winter/Spring 2024 slide image

Investor Presentation - Winter/Spring 2024

~430 RX BRANDS WITH $100M+ IN U.S. SALES Estimated Doximity Share of HCP Marketing Budgets at Customers¹ Note: Each box represents one brand with $100M+ in U.S. sales doximity 1. As of March 31, 2023 >50% 20-50% 5-20% <5% No Revenue In Trailing 12 Months Est. Share of Total HCP Marketing Budgets¹ <5% Current Penetration Potential Expansion Investor Presentation - February, 2024
View entire presentation